Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Neuralgia 2Head and Neck Neoplasms 1Breast Neoplasms 1Agnosia 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Capsaicin × Clear all
NCT04704453 2026-04-14

TEC-ORL

Institut Claudius Regaud

Phase 2 Completed
13 enrolled
Head & Neck

Head and Neck Neoplasms, Neuralgia

NCT06807164 2026-03-27

SerCaBot

Centre Oscar Lambret

Phase 2 Recruiting
123 enrolled
Breast

Agnosia, Breast Neoplasms

NCT03317613 2022-02-08

CAPSONCO

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Completed
84 enrolled

Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡